1. Home
  2. PCT vs KALV Comparison

PCT vs KALV Comparison

Compare PCT & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

HOLD

Current Price

$12.45

Market Cap

2.3B

Sector

Utilities

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.80

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCT
KALV
Founded
2015
N/A
Country
United States
United States
Employees
174
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.0B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PCT
KALV
Price
$12.45
$26.80
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$13.00
$32.60
AVG Volume (30 Days)
4.9M
3.9M
Earning Date
05-06-2026
07-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$50,000,000.00
Revenue This Year
$380.44
$185.42
Revenue Next Year
$203.33
$59.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
495.66
52 Week Low
$4.93
$9.83
52 Week High
$17.37
$26.85

Technical Indicators

Market Signals
Indicator
PCT
KALV
Relative Strength Index (RSI) 69.82 74.29
Support Level $7.87 $14.22
Resistance Level $15.13 $26.85
Average True Range (ATR) 0.86 0.06
MACD 0.05 -0.28
Stochastic Oscillator 79.19 76.47

Price Performance

Historical Comparison
PCT
KALV

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: